Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.466.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.222NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.222NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.222NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.470NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.470NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.470NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.31 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.31 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.31 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.51 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-18259.5US
AY.51 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.51 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-15848China
AY.122.5 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.122.5 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.122.5 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.40.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.40.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.40.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.13.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.13.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.10.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.10.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.10.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GS.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HG.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HG.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HG.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.323NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.323NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.323NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FU.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FU.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FU.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used